Search research articles
Contact Us
Filters
Showing results (81-90 of 129) with videos related to
Page
of 13
Sort By:
Breast Cancer Research and Treatment
|
June 7, 2020
N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancer
Roberto A Leon-Ferre, Edith A Perez, David W Hillman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 2, 2011
Physical and economic consequences of climate change in Europe
Juan-Carlos Ciscar, Ana Iglesias, Luc Feyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2019
Effects of Age and Immune Landscape on Outcome in HER2-Positive Breast Cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) Trials
Saranya Chumsri, Daniel J Serie, Zhuo Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2011
Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancer
Edith A Perez, Vera J Suman, Nancy E Davidson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2020
Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib Study
Shanu Modi, Haeseong Park, Rashmi K Murthy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 14, 2018
High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance)
Saranya Chumsri, Jeff Sperinde, Heshan Liu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 5, 2021
Body Mass Index and Weight Change in Patients With HER2-Positive Early Breast Cancer: Exploratory Analysis of the ALTTO BIG 2-06 Trial
Samuel Martel, Matteo Lambertini, Dominique Agbor-Tarh, et al.
Journal for Immunotherapy of Cancer
|
December 18, 2024
Preclinical development of three novel CARs targeting CD79b for the treatment of non-Hodgkin's lymphoma and characterization of the loss of the target antigen
Esperanza Esquinas, Alvaro Moreno-Sanz, Victor Sandá, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2025
Pembrolizumab in Combination with Binimetinib in Patients with Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer
Saranya Chumsri, Joseph J Larson, Emily Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2011
Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437
Monica M Reinholz, Kathleen A Kitzmann, Kathleen Tenner, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 129) with videos related to
Sort By:
Page
of 13
Breast Cancer Research and Treatment
|
June 7, 2020
N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancer
Roberto A Leon-Ferre, Edith A Perez, David W Hillman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 2, 2011
Physical and economic consequences of climate change in Europe
Juan-Carlos Ciscar, Ana Iglesias, Luc Feyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2019
Effects of Age and Immune Landscape on Outcome in HER2-Positive Breast Cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) Trials
Saranya Chumsri, Daniel J Serie, Zhuo Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2011
Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancer
Edith A Perez, Vera J Suman, Nancy E Davidson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2020
Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib Study
Shanu Modi, Haeseong Park, Rashmi K Murthy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 14, 2018
High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance)
Saranya Chumsri, Jeff Sperinde, Heshan Liu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 5, 2021
Body Mass Index and Weight Change in Patients With HER2-Positive Early Breast Cancer: Exploratory Analysis of the ALTTO BIG 2-06 Trial
Samuel Martel, Matteo Lambertini, Dominique Agbor-Tarh, et al.
Journal for Immunotherapy of Cancer
|
December 18, 2024
Preclinical development of three novel CARs targeting CD79b for the treatment of non-Hodgkin's lymphoma and characterization of the loss of the target antigen
Esperanza Esquinas, Alvaro Moreno-Sanz, Victor Sandá, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2025
Pembrolizumab in Combination with Binimetinib in Patients with Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer
Saranya Chumsri, Joseph J Larson, Emily Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2011
Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437
Monica M Reinholz, Kathleen A Kitzmann, Kathleen Tenner, et al.
Page
of 13